Impact of Metabolic Syndrome on Health-related Quality of Life and Obesity-related Hormone in Obese Women

代謝症候群對肥胖婦女健康相關生活品質與肥胖相關荷爾蒙之影響

劉佳祐(Chia-Yu Liu) ； 陳怡如(I-Ju Chen) ； 邱榮鵬(Jung-Peng Chiu) ； 許中華(Chung-Hua Hsu)

《北市醫學雜誌》 10卷3期 (2013/09) Pp. 182-194

https://doi.org/10.6200/TCMJ.2013.10.3.02

摘要

Objective: Obesity is an important health issue and risk factor in the development of cardiovascular disease and type 2 diabetes mellitus. It is also an underlying cause of metabolic syndrome (MS). Both obesity and MS have significant impact on health-related quality of life (HRQOL). Few studies have assessed the relationship between MS, HRQOL, and obesity-related hormone peptides in obese women. The present study investigated the impact of MS components on HRQOL and obesity-related hormone peptides in obese women. Methods: This study enrolled 259 obese women with body mass index (BMI) ≥ 27 kg/m^2 and waist circumference ≥ 80 cm. Their anthropometric characteristics, biochemical characteristic, HRQOL, and obesity-related hormone peptides including insulin, leptin, ghrelin, and adiponectin were evaluated. All subjects met at least one of the five MS components defined in the National Cholesterol Education Program, Adult Treatment Panel III. Results: Obese women with MS (n = 150) had lower HROQL in physical domain, lower level of adiponectin, but higher level of leptin and ghrelin than those without. With increasing number of MS components, lower HRQOL in physical domain, lower adiponectin, higher insulin, insulin resistance, and ghrelin were noted with statistical significance in the linear trend test (all p ＜ 0.001, except p = 0.025 for ghrelin). Leptin and other domains of HRQOL were not associated with the number of MS components. Conclusions: Obese women with MS had worse physical aspect of HRQOL than those without. The negative impact of MS components on physical aspect of HRQOL and adiponectin in obese women was noted. Future studies should focus on the relationship between HRQOL and obesity-related hormone peptides.

關鍵字

肥胖 ； 代謝症候群 ； 健康相關生活品質 ； 肥胖相關荷爾蒙

並列摘要

Objective: Obesity is an important health issue and risk factor in the development of cardiovascular disease and type 2 diabetes mellitus. It is also an underlying cause of metabolic syndrome (MS). Both obesity and MS have significant impact on health-related quality of life (HRQOL). Few studies have assessed the relationship between MS, HRQOL, and obesity-related hormone peptides in obese women. The present study investigated the impact of MS components on HRQOL and obesity-related hormone peptides in obese women. Methods: This study enrolled 259 obese women with body mass index (BMI) ≥ 27 kg/m^2 and waist circumference ≥ 80 cm. Their anthropometric characteristics, biochemical characteristic, HRQOL, and obesity-related hormone peptides including insulin, leptin, ghrelin, and adiponectin were evaluated. All subjects met at least one of the five MS components defined in the National Cholesterol Education Program, Adult Treatment Panel III. Results: Obese women with MS (n = 150) had lower HROQL in physical domain, lower level of adiponectin, but higher level of leptin and ghrelin than those without. With increasing number of MS components, lower HRQOL in physical domain, lower adiponectin, higher insulin, insulin resistance, and ghrelin were noted with statistical significance in the linear trend test (all p ＜ 0.001, except p = 0.025 for ghrelin). Leptin and other domains of HRQOL were not associated with the number of MS components. Conclusions: Obese women with MS had worse physical aspect of HRQOL than those without. The negative impact of MS components on physical aspect of HRQOL and adiponectin in obese women was noted. Future studies should focus on the relationship between HRQOL and obesity-related hormone peptides.

並列關鍵字

metabolic syndrome ； health related quality of life ； obesity-related hormone peptides

參考文獻

Dixon JB. The effect of obesity on health outcomes. Mol. Cell. Endocrinol 2010; 316:104-108.

Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J. Formos. Med. Assoc. 2006; 105: 626-635.

Hwang LC, Chen SC, Chen CJ. Increased risk of mortality from overweight and obesity in middle-aged individuals from six communities in Taiwan. J. Formos. Med. Assoc. 2011; 110:290-298.

Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol 2005; 42 Suppl 1: S3-8.

Paul S, Smith L. The metabolic syndrome in women: a growing problem for cardiac risk. J. Cardiovasc Nurs 2005; 20:427-432.